Table 1. Patient Demographics.
High Dose Vaginal Misoprostol (n= 20) | Concentrated Oxytocin + Low-dose Vaginal PGE1 (n=18) | p value | |
---|---|---|---|
|
|
|
|
Age (yr) * | 25.3 ± 7.0 | 24.3 ± 6.1 | 0.652 |
Gestational age (wk) * | 20.3 ± 2.2 | 20.5 ± 1.8 | 0.793 |
Height (inches) * | 64.7 ± 2.3 | 63.8 ± 4.1 | 0.426 |
Weight (lb) * | 160.4 ± 28.2 | 153.2 ± 28.8 | 0.452 |
Initial Cervical Dilation (cm) * | 0.1 ± 0.3 | 0.0 ± 0.0 | 0.163 |
Parity: | |||
Primiparous | 50.0% (10/20) | 50.0% (9/18) | |
Multiparous | 50.0% (10/20) | 50.0% (9/18) | 1.000 |
Race: | |||
Caucasian | 50.0% (10/20) | 38.9% (7/18) | |
African-American | 50.0% (10/20) | 61.1% (11/18) | 0.492 |
Mean± Standard Deviation